RESUMO
The ever-decreasing cost of sequencing is ushering in a new era in genomic medicine. Laura Bonetta reports on new studies that provide a glimpse of the opportunities ahead.
Assuntos
Genoma , Análise de Sequência de DNA/economia , Análise de Sequência de DNA/tendências , Doença/genética , Humanos , Neoplasias/genética , Neoplasias/metabolismoRESUMO
For years, the general public have been helping scientists to track weather, count birds, and observe the universe. Now such citizen scientists are starting to tackle research projects in the life sciences. Laura Bonetta reports.
Assuntos
Genômica/métodos , Proteômica/métodos , Participação da Comunidade , InternetRESUMO
Twitter needs no introduction. This "microblogging" service has gained tremendous popularity in the 2 years since its launch. Yet, most scientists are steering clear of it. Laura Bonetta speaks to some who have found value in tweeting.
Assuntos
Biologia , Tecnologia/tendências , Jornalismo Médico/normas , Publicações Periódicas como AssuntoRESUMO
Delivery of RNA-based therapeutics to specific tissues for treating a variety of diseases faces many hurdles. But with several clinical trials and a slew of studies in animal models underway, the future of RNA-based therapeutics seems bright.
Assuntos
Tratamento Farmacológico , RNA/uso terapêutico , Animais , Ensaios Clínicos como Assunto , Humanos , Modelos AnimaisRESUMO
A European law that prevents the patenting of discoveries that contravene morality is causing confusion when it comes to human embryonic stem cells. The ensuing debate is markedly different from the one in the United States, where the scope of stem cell patents and their licensing are under challenge.
Assuntos
Tecnologia Biomédica/ética , Tecnologia Biomédica/legislação & jurisprudência , Patentes como Assunto/ética , Células-Tronco , Animais , Europa (Continente) , HumanosRESUMO
A new type of company is offering to scan a person's genome and reveal the information it holds for as little as $1000. Are these services fun novelty items or do they provide valuable information that will help people take better care of their health?
Assuntos
Testes Genéticos/métodos , Genoma Humano , Polimorfismo de Nucleotídeo Único , Análise de Sequência de DNA/métodos , Testes Genéticos/economia , Humanos , Indústrias , Saliva/metabolismo , Análise de Sequência de DNA/economiaRESUMO
Over the next couple of years, NIH will be revising its process of reviewing grant applications. The planned changes will make the NIH system more similar in some ways to those of European funding agencies, while retaining many unique features.
Assuntos
Pesquisa Biomédica/economia , National Institutes of Health (U.S.) , Revisão da Pesquisa por Pares , Apoio à Pesquisa como Assunto , Estados UnidosRESUMO
The new US President will be selecting the next director of the National Institutes of Health (NIH) at a time when the agency faces many challenges. Priorities for the new director include boosting the NIH coffers in troubled economic times, balancing funding for basic and translational research, and helping young scientists.